Imidazo[1,2-A]Pyridine: Potent Biological Activity, SAR and Docking In-vestigations (2017-2022)

咪唑吡啶 抗真菌 化学 对接(动物) 吡啶 组合化学 药理学 医学 有机化学 护理部 皮肤病科
作者
Aditya Narayan,Shivkant Patel,Sunil Baile,Surabhi Jain,Smriti Sharma
出处
期刊:Infectious disorders drug targets [Bentham Science]
卷期号:24
标识
DOI:10.2174/0118715265274067240223040333
摘要

Regarding scientific research, Imidazo[1,2-a] pyridine derivatives are constantly being developed due to the scaffold's intriguing chemical structure and varied bio-logical activity. They are distinctive organic nitrogen-bridged heterocyclic compounds that have several uses in medicines, organometallics and natural products. It has become a vital tool for medicinal chemists.In order to gather scientific information on Imidazo[1,2-a] pyridines derivative, Google, PubMed, Scopus, Google Scholar, and other databases were searched. In the current study, the medicinal value and therapeutic effect of Imidazo[1,2-a] pyridines were investigated using above mentioned databases. The current study analyzed the detailed pharmacological ac-tivities of Imidazo[1,2-a] pyridine analogs through literature from diverse scientific research works.Due to its wide range of biological activities, including antiulcer, anticonvulsant, anti-protozoal, anthelmintic, antiepileptic, antifungal, antibacterial, analgesic, antiviral, anticancer, anti-inflammatory, antituberculosis, and antitumor properties, imidazopyridine is one of the most significant structural skeletons in the field of natural and pharmaceutical products. An imidazopyridine scaffold serves as the basis for a number of therapeutically utilized medica-tions, including zolpidem, alpidem, olprinone, zolimidine, and necopidem.This comprehensive study covers the period of the last five years, and it sheds light on the developments and emerging pharmacological actions of Imidazo[1,2-a] pyridines. Additionally, the structure-activity relationship and molecular docking studies are carefully documented throughout the paper, providing medicinal chemists with a clear picture for devel-oping new drugs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
开放大山发布了新的文献求助30
刚刚
1秒前
2秒前
4秒前
Ashmitte发布了新的文献求助10
5秒前
顾矜应助禹子骞采纳,获得10
6秒前
Hello应助Azur1采纳,获得10
7秒前
Zureil发布了新的文献求助10
7秒前
Agoni完成签到,获得积分10
8秒前
初夏发布了新的文献求助10
9秒前
10秒前
面向杂志编论文应助bo采纳,获得10
11秒前
拼搏问枫完成签到,获得积分10
11秒前
YINZHE应助花花采纳,获得10
11秒前
Jiayou Zhang完成签到,获得积分10
11秒前
Ashmitte完成签到,获得积分10
14秒前
完美世界应助LHL采纳,获得10
14秒前
cooky发布了新的文献求助50
15秒前
coco完成签到,获得积分10
16秒前
fufufufu完成签到,获得积分10
17秒前
18秒前
秃秃24发布了新的文献求助10
19秒前
冷静的傲安关注了科研通微信公众号
21秒前
23秒前
灿灿完成签到,获得积分20
23秒前
26秒前
小狐狸发布了新的文献求助30
30秒前
smottom应助沉默的短靴采纳,获得10
30秒前
muyi完成签到 ,获得积分10
31秒前
152455发布了新的文献求助10
32秒前
七里香发布了新的文献求助10
35秒前
上官若男应助奶油大卡采纳,获得10
37秒前
外向白开水完成签到 ,获得积分10
38秒前
丑丑的宝贝女儿完成签到,获得积分10
38秒前
宋虹发布了新的文献求助10
39秒前
43秒前
flamezzz完成签到,获得积分10
43秒前
乐乐应助脆脆应答采纳,获得10
44秒前
Suchen应助劈里啪啦采纳,获得10
45秒前
情怀应助yk123采纳,获得20
45秒前
高分求助中
【本贴是提醒信息,请勿应助】请在求助之前详细阅读求助说明!!!! 20000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
The Three Stars Each: The Astrolabes and Related Texts 900
Yuwu Song, Biographical Dictionary of the People's Republic of China 800
Multifunctional Agriculture, A New Paradigm for European Agriculture and Rural Development 600
Bernd Ziesemer - Maos deutscher Topagent: Wie China die Bundesrepublik eroberte 500
A radiographic standard of reference for the growing knee 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2480494
求助须知:如何正确求助?哪些是违规求助? 2143063
关于积分的说明 5464952
捐赠科研通 1865819
什么是DOI,文献DOI怎么找? 927457
版权声明 562931
科研通“疑难数据库(出版商)”最低求助积分说明 496183